2023年2月15日

新闻分享这篇文章提供的韩国公司继续增长和扩大美国的存在与斯坦福大学附属启动加速器StartX是世界公认领先的创业加速器和提供了一个独特的组合资源和网络的机会。”——凯文·崔首席执行官Mediwhale帕洛阿尔托,加州,美国,2月15日2023 / EINPresswire.com——Mediwhale AI-empowered健康诊断公司未来使用视网膜扫描诊断心脏和肾脏疾病风险快速、轻松地,今天宣布它已被接受到2023群StartX独家加速器项目隶属于斯坦福大学和斯坦福大学医疗保健。该项目目前正在进行中,贯穿4月和Mediwhale将继续积极StartX社区成员。StartX致力于帮助企业家们把他们的创新想法生活,提供他们所需要的成长和成功。这个程序提供了一个广泛的服务和资源,包括指导、教育研讨会,获得投资者,和一群志同道合的企业家。StartX是一种高度选择性的程序,严格的面试过程。Mediwhale选择基于其尖端技术和业务增长,即使没有一个斯坦福连接。Mediwhale位于韩国、美国市场并不陌生。公司目前活跃在HeartX健康科技加速器项目在阿肯色州,是一个创新的主宾在国际消费电子展上,给ASN肾周会议上的报告和美国心脏协会科学会议,所有在2022年。Mediwhale Reti-Intelligence技术,专注于心脏健康(Reti-CVD) pre-application阶段获得FDA的批准。 The Reti-Intelligence technology uses deep learning algorithms to holistically assess a patient’s health using retinal images and can detect disease risks even before symptoms appear. Reti-Intelligence leverages non-invasive retinal scans through a common fundus camera combined with extensively trained algorithms to diagnose disease risks conveniently for both the patient and physician in under minute. The initial assessment by a family doctor can save patients both money and time, with wait times to see specialists often exceeding a month. Early detection is key in averting a potentially irreversible health problem. The Mediwhale focus areas are cardiovascular (Reti-CVD), kidneys (Reti-CKD), eyes (Reti-Eye), and aging (Reti-Age). The accuracy and dependability of Reti-Intelligence has landed it approvals around Asia and Europe. Reti-Eye shows a minimum of 96% accuracy and Reti-CVD predicts cardiovascular risk as accurately as a cardiac CT. "We are thrilled to be a part of this StartX community," said Kevin Choi, CEO of Mediwhale. "StartX is a recognized leader in the startup accelerator world and provides a unique combination of resources and networking opportunities. This will be an excellent opportunity for us to connect with other U.S. startups and also contribute to the exceptional StartX community." The Program concludes with an in-person event in April and participants are given permanent access to a suite of services and tools, as well as the Silicon Valley-based StartX office space. About Mediwhale Mediwhale is the AI-empowered health diagnostics company that uses non-invasive retina scans to help prevent heart and kidney diseases. Mediwhale’s Reti-Intelligence suite of services uses deep learning algorithms to detect disease risks even before symptoms appear. Mediwhale has been dedicated to making preventative care more affordable, accessible, safe, and convenient since being founded in 2016 in South Korea. Luke Keding